134 related articles for article (PubMed ID: 6817524)
1. [Current theories on the pathogenesis of amyloidosis].
Kordecki H
Wiad Lek; 1982 Oct; 35(18):1171-6. PubMed ID: 6817524
[No Abstract] [Full Text] [Related]
2. [Amyloidosis in patients with rheumatoid arthritis].
Bluszcz-Roznowska A; Kucharz EJ
Przegl Lek; 2005; 62(12):1532-7. PubMed ID: 16786790
[TBL] [Abstract][Full Text] [Related]
3. [Systemic amyloidosis associated with plasmacytoma. I. Present etiopathogenic findings].
Sakalová A; Tichý M; Horváth A; Hrubisko M
Vnitr Lek; 1985 Jun; 31(6):572-6. PubMed ID: 4036024
[No Abstract] [Full Text] [Related]
4. AA amyloidosis associated with macroglobulinemia.
Tatara R; Nagai T; Kobayashi H; Hatano K; Suzuki T; Muroi K; Ozawa K
Int J Hematol; 2010 Nov; 92(4):675-7. PubMed ID: 20953745
[No Abstract] [Full Text] [Related]
5. Amyloid proteins, precursors, mediator, and enhancer.
Cohen AS; Shirahama T; Sipe JD; Skinner M
Lab Invest; 1983 Jan; 48(1):1-4. PubMed ID: 6401828
[No Abstract] [Full Text] [Related]
6. Amyloidosis: a familiar problem in the light of current pathogenetic developments.
Kisilevsky R
Lab Invest; 1983 Oct; 49(4):381-90. PubMed ID: 6353059
[No Abstract] [Full Text] [Related]
7. [Check-valve-mechanism in Waldenstrom's macroglobulinemia with pericollagen amyloidosis].
Missmahl HP; Gelinsky P; Braun HJ; Dold U
Med Welt; 1969 Jan; 1():39-41. PubMed ID: 4975603
[No Abstract] [Full Text] [Related]
8. [AL- and AA-amyloidosis (the status of the problem)].
Kochubeĭ LN; Vinogradova OM; Serov VV; Vasil'eva NA; Tomas NIu
Klin Med (Mosk); 1988 Aug; 66(8):7-16. PubMed ID: 3057283
[No Abstract] [Full Text] [Related]
9. Serum amyloid A and protein AA: molecular mechanisms of a transmissible amyloidosis.
Westermark GT; Westermark P
FEBS Lett; 2009 Aug; 583(16):2685-90. PubMed ID: 19393650
[TBL] [Abstract][Full Text] [Related]
10. Waldenström's macroglobulinemia associated with AA amyloidosis.
Gardyn J; Schwartz A; Gal R; Lewinski U; Kristt D; Cohen AM
Int J Hematol; 2001 Jul; 74(1):76-8. PubMed ID: 11530809
[TBL] [Abstract][Full Text] [Related]
11. [Amyloidosis: new facts, disputable and unresolved problems].
Serov VV
Arkh Patol; 1989; 51(10):3-10. PubMed ID: 2692539
[TBL] [Abstract][Full Text] [Related]
12. Amyloidosis with IgM monoclonal gammopathies.
Gertz MA; Kyle RA
Semin Oncol; 2003 Apr; 30(2):325-8. PubMed ID: 12720162
[TBL] [Abstract][Full Text] [Related]
13. [Amyloid nephropathy disclosing Waldenström macroglobulinemia].
Schillinger F; Montagnac R; Milcent T; Mehaut S; Hopfner C
Presse Med; 1989 May; 18(21):1081. PubMed ID: 2524824
[No Abstract] [Full Text] [Related]
14. [Amyloidosis].
Moszczyński P
Pieleg Polozna; 1984; (10):16-7. PubMed ID: 6570234
[No Abstract] [Full Text] [Related]
15. Diagnostic challenges of amyloidosis in Waldenström macroglobulinemia.
Palladini G; Merlini G
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):244-6. PubMed ID: 23474147
[TBL] [Abstract][Full Text] [Related]
16. The amino acid sequence of an AL-protein, AL-KH, isolated from the heart of a patient with Waldenstroms macroglobulinemia and amyloidosis.
Kjaeraas S; Husby G; Sletten K
Amyloid; 2006 Dec; 13(4):260-2. PubMed ID: 17107886
[TBL] [Abstract][Full Text] [Related]
17. Some unsolved problems in the amyloid diseases.
Franklin EC
Am J Med; 1979 Mar; 66(3):365-7. PubMed ID: 107798
[No Abstract] [Full Text] [Related]
18. [Effective long-term use of colchicine in secondary AA-amyloidosis].
Rameev VV; Chegaeva TV; Proskurneva EP
Ter Arkh; 1999; 71(1):54-7. PubMed ID: 10097303
[No Abstract] [Full Text] [Related]
19. Humoral and cellular aspects of amyloid disease: present status.
Scheinberg MA; Wohlgethan JR; Cathcart ES
Prog Allergy; 1980; 27():250-76. PubMed ID: 6766217
[No Abstract] [Full Text] [Related]
20. [Relationship between monoclonal gammopathies and amyloidoses].
Braun HJ
Hamatol Bluttransfus; 1976; 18():419-32. PubMed ID: 823080
[No Abstract] [Full Text] [Related]
[Next] [New Search]
